Dermal Fillers

Dermal fillers are designed to help enhance natural features by adding volume to certain areas of your face.

Derma fillers contain hyaluronic acid, which is a naturally occurring sugar found in the body.

Hyaluronic acid works by holding in water at the injection site and acting as a cushioning agent. It adds temporary volume and a smoother appearance to skin. Hyaluronic acid is best known as a “filler” and is used to give volume to lips or to contour other areas of the face.

At NEO Skin Lab, we use Juvéderm®, Belotero and Restylane Fillers.

Juvederm products are developed using Hylacross technology to allow a smoother, malleable gel. Juvéderm® Ultra Plus products contain more highly cross-linked formulations for volumising and correction of deeper folds and wrinkles. These products also contain the local anaesthetic Lidocaine for a more comfortable injection; it numbs the treatment area within minutes.

Most patients need one treatment to achieve optimal results. Re-injections may be needed, typically between nine months and one year after the initial injection. Smaller injections (about half the amount) are needed for repeat procedures. Cosmetic injectable procedures are not recommended during pregnancy or while breastfeeding.

Product Information:

The JUVÉDERM® range of injectable gels are medical devices for use in adults. JUVÉDERM® ULTRA XC and JUVÉDERM® ULTRA PLUS XC contain 24mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. JUVÉDERM® ULTRA XC is for filling medium-sized depressions of the skin as well as for lip definition. JUVÉDERM® ULTRA PLUS XC is for filling mid and/or deep depressions of the skin as well as for lip definition and enhancement. JUVÉDERM® VOLUMA® with lidocaine contains 20mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended to restore volume of the face. JUVÉDERM® VOLIFT® with lidocaine contains 17.5mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended for the treatment of deep skin depressions, for face contouring or volume restoration of the face. JUVÉDERM® VOLBELLA® with lidocaine contains 15mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended for the treatment of any fine lines and medium-sized skin depressions or the enhancement and pouting of lips. JUVEDERM® VOLITE™ contains 12 mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended to be used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity, via intradermal injection. All JUVÉDERM® products should be administered only by a trained healthcare professional. JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC and JUVEDERM® VOLITE™ should not be injected into the eyelids. JUVÉDERM® VOLUMA® with lidocaine should not be injected in the periorbital area (eyelids, under-eye area, crow’s feet), glabellar region or in the lips. JUVÉDERM® VOLBELLA® with lidocaine should not be injected into the eyelids. Application in the bags under the eyes is reserved for trained specialists. JUVÉDERM® VOLIFT® with lidocaine should not be injected in the periorbital area (eyelids, under-eye area, crow’s feet) and glabellar region. You should not receive treatment with any JUVÉDERM® product if you are below 18 years of age, have untreated epilepsy, history of hypertrophic scars or porphyria, or if you are pregnant or breastfeeding, hypersensitivity to ingredients including hyaluronic acid, lidocaine or amide-type local anaesthetics, any areas of cutaneous inflammation and/or infections, or if you have just had laser treatment, deep chemical peel or dermabrasion. Precautions: Caution is required if you have received treatment with another dermal filler; if you have a history of or are currently suffering an auto-immune disease, severe multiple allergies, anaphylactic shock, streptococcal disease, symptoms of cardiac conduction disorders; or if you are taking certain medications including anti-coagulants or certain drugs that reduce/inhibit hepatic metabolism. Avoid makeup for 12 hours after injection and prolonged exposure to sunlight/UV light/extreme temperatures for 2 weeks. Adverse effects reported after treatment with JUVÉDERM® range of fillers have included immediate or delayed injection site inflammatory reactions (redness/swelling/ itching/pain on pressure) persisting a week post treatment, haematomas, induration or nodules, discolouration, weak filling effect, risk of infection, abscess formation, granuloma, necrosis or hypersensitivity. Please ask your doctor or request for the Directions For Use for complete list of precautions and adverse effects per respective filler. JUVÉDERM® injectable gels are not funded on the New Zealand Pharmaceutical Scheme. You will need to pay for this treatment. Normal Doctors visit fees apply. Speak to your specialist about your own situation and about the benefits/ risks of this procedure in appearance medicine. If you have any side effects or concerns speak to your doctor. Note: JUVÉDERM® treatment may last up to 1–2 years and further courses of treatment may be necessary. (September 2018).

™®Trademark(s) and registered trademark(s) of Allergan, Inc. Allergan Australia Pty Ltd. 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan.

Restylane®Restylane is an unfunded Treatment that you pay for. Ask your Doctor if Restylane is right for you. Normal Doctors charges apply. Restylane is an injectable intradermal implant containing Hyaluronic acid, stabilized 20 mg/ml. Restylane is used for facial tissue augmentation and lip enhancement. Restylane should only be injected by a medical professional. Tell your medical professional if you have a bleeding disorder or if you are being treated with blood thinning medicines, or any other medicines you are taking. Precautions: Allergy to Hyaluronic acid or any active ingredients. Restylane should not be used where there is active skin disease, inflammation or related conditions. Do not use if pregnant or breastfeeding, or in children. Avoid intense heat or cold after treatment until swelling and redness have resolved. Side effects: common injection-related reactions might occur, including redness, swelling, pain, itching, bruising, tenderness or lumpiness at the implant site. Typically, these resolve in a few days to a week. Tell your medical professional if you experience any side effects. For further information ask your medical professional. Q-Med c/o Pharmacy Retailing (NZ) t/a Healthcare Logistics, Auckland 0800 174 104.

 Belotero® is hyaluronic acid dermal filler. It is used to improve the look of facial fold and wrinkles and restore volume, including contouring, shaping and volumising of the lips. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. You should tell your practitioner and avoid treatment with BELOTERO® if you: have had an allergic reaction to any of the ingredients; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing, inflamed or infected skin, or general infection; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, epilepsy, liver or kidney problems, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner.

Copyright © 2019. Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL). 58 Richard Pearse Drive, Mangere, Auckland 2022 All rights reserved. Belotero ® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA